Lymphocyte cytosolic protein 1 is a chronic lymphocytic leukemia membrane-associated antigen critical to niche homing

Chronic lymphocytic leukemia: molecular heterogeneity revealed by high-throughput genomics

(2013) Dan A Landau et al.   Genome Medicine

The B-cell receptor signaling pathway as a therapeutic target in CLL

(2012) J. A. Woyach et al.   BLOOD

Tetraspanin CD37 Directly Mediates Transduction of Survival and Apoptotic Signals

(2012) Rosa Lapalombella et al.   CANCER CELL

Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia

(2012) Preetesh Jain et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

L-Plastin Regulates Polarization and Migration in Chemokine-Stimulated Human T Lymphocytes

(2012) M. Freeley et al.   JOURNAL OF IMMUNOLOGY

A unique proteomic profile on surface IgM ligation in unmutated chronic lymphocytic leukemia

(2011) A. Perrot et al.   BLOOD

Exosome-loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with glioma

(2011) Ning Bu et al.   JOURNAL OF NEURO-ONCOLOGY

Nurture versus Nature: The Microenvironment in Chronic Lymphocytic Leukemia

(2011) J. A. Burger   Hematology-American Society of Hematology Education Program

The clinical application of monoclonal antibodies in chronic lymphocytic leukemia

(2010) S. M. Jaglowski et al.   BLOOD

The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor

(2010) M. Hudecek et al.   BLOOD

Restoring the functional immunogenicity of chronic lymphocytic leukemia using epigenetic modifiers

(2010) Jason A. Dubovsky et al.   LEUKEMIA RESEARCH

Quantitative Kinetic Study of the Actin-Bundling Protein L-Plastin and of Its Impact on Actin Turn-Over

(2010) Ziad Al Tanoury et al.   PLoS One

Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway

(2009) R. Lapalombella et al.   BLOOD

Circumventing Immune Tolerance Through Epigenetic Modification

(2009) Jason Dubovsky et al.   CURRENT PHARMACEUTICAL DESIGN

Healthy individuals have T-cell and antibody responses to the tumor antigen cyclin B1 that when elicited in mice protect from cancer

(2009) L. A. Vella et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a

(2008) T. Fukuda et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Exosome Function: From Tumor Immunology to Pathogen Biology

(2008) Jeffrey S. Schorey et al.   TRAFFIC